Originally published on Cannabis Health The Medical Cannabis Clinicians Society (MCCS) has published what it describes as a crucial step
UK medical cannabis operator Kanabo Group has fallen into administration, seeing the last remaining member of the first four cannabis
Cannim Group Pty, the international medical cannabis company with operations spanning the UK, Australia, the US and Canada, has entered
Airo Brands, a US multi-state CPG company focused on proprietary cannabis products, in partnership with Jupiter Research LLC, has received
Curaleaf Laboratories has been confirmed as headline sponsor of the inaugural Cannabis Health Symposium, taking place on 25 November 2025
As Europe’s medical cannabis market shifts from a focus on growth to pharmaceutical discipline, PHCANN International has emerged as a
The UK’s medical cannabis industry is now the second largest in Europe, second only to Germany, thanks to consistent and
The UK’s cannabis industry, one of the largest on the planet, sits at a crossroads. Does it choose the pharmaceutically
Curaleaf Laboratories has announced the launch of the UK’s first CE-certified liquid medical cannabis inhaler, aiming to address growing patient
Below, we’ve summarised the key insights from the vibrant and diverse discussions throughout Day 2 of Cannabis Europa 2025. If you’re keen to dive into the details, we’ll be exploring each session in more detail over the coming weeks.
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
